Biopharmaceuticals from microorganisms: from production to purification
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Microbiology |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822016000500051 |
Resumo: | ABSTRACT The use of biopharmaceuticals dates from the 19th century and within 5-10 years, up to 50% of all drugs in development will be biopharmaceuticals. In the 1980s, the biopharmaceutical industry experienced a significant growth in the production and approval of recombinant proteins such as interferons (IFN α, β, and γ) and growth hormones. The production of biopharmaceuticals, known as bioprocess, involves a wide range of techniques. In this review, we discuss the technology involved in the bioprocess and describe the available strategies and main advances in microbial fermentation and purification process to obtain biopharmaceuticals. |
id |
SBM-1_f0b216eb72a3a887038b00dcc31163fc |
---|---|
oai_identifier_str |
oai:scielo:S1517-83822016000500051 |
network_acronym_str |
SBM-1 |
network_name_str |
Brazilian Journal of Microbiology |
repository_id_str |
|
spelling |
Biopharmaceuticals from microorganisms: from production to purificationBiopharmaceuticalsFermentation processBiotechnologyUpstream processDownstream processABSTRACT The use of biopharmaceuticals dates from the 19th century and within 5-10 years, up to 50% of all drugs in development will be biopharmaceuticals. In the 1980s, the biopharmaceutical industry experienced a significant growth in the production and approval of recombinant proteins such as interferons (IFN α, β, and γ) and growth hormones. The production of biopharmaceuticals, known as bioprocess, involves a wide range of techniques. In this review, we discuss the technology involved in the bioprocess and describe the available strategies and main advances in microbial fermentation and purification process to obtain biopharmaceuticals.Sociedade Brasileira de Microbiologia2016-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822016000500051Brazilian Journal of Microbiology v.47 suppl.1 2016reponame:Brazilian Journal of Microbiologyinstname:Sociedade Brasileira de Microbiologia (SBM)instacron:SBM10.1016/j.bjm.2016.10.007info:eu-repo/semantics/openAccessJozala,Angela FaustinoGeraldes,Danilo CostaTundisi,Louise LacalendolaFeitosa,Valker de AraújoBreyer,Carlos AlexandreCardoso,Samuel LeiteMazzola,Priscila GavaOliveira-Nascimento,Laura deRangel-Yagui,Carlota de OliveiraMagalhães,Pérola de OliveiraOliveira,Marcos Antonio dePessoa Jr,Adalbertoeng2017-01-18T00:00:00Zoai:scielo:S1517-83822016000500051Revistahttps://www.scielo.br/j/bjm/ONGhttps://old.scielo.br/oai/scielo-oai.phpbjm@sbmicrobiologia.org.br||mbmartin@usp.br1678-44051517-8382opendoar:2017-01-18T00:00Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM)false |
dc.title.none.fl_str_mv |
Biopharmaceuticals from microorganisms: from production to purification |
title |
Biopharmaceuticals from microorganisms: from production to purification |
spellingShingle |
Biopharmaceuticals from microorganisms: from production to purification Jozala,Angela Faustino Biopharmaceuticals Fermentation process Biotechnology Upstream process Downstream process |
title_short |
Biopharmaceuticals from microorganisms: from production to purification |
title_full |
Biopharmaceuticals from microorganisms: from production to purification |
title_fullStr |
Biopharmaceuticals from microorganisms: from production to purification |
title_full_unstemmed |
Biopharmaceuticals from microorganisms: from production to purification |
title_sort |
Biopharmaceuticals from microorganisms: from production to purification |
author |
Jozala,Angela Faustino |
author_facet |
Jozala,Angela Faustino Geraldes,Danilo Costa Tundisi,Louise Lacalendola Feitosa,Valker de Araújo Breyer,Carlos Alexandre Cardoso,Samuel Leite Mazzola,Priscila Gava Oliveira-Nascimento,Laura de Rangel-Yagui,Carlota de Oliveira Magalhães,Pérola de Oliveira Oliveira,Marcos Antonio de Pessoa Jr,Adalberto |
author_role |
author |
author2 |
Geraldes,Danilo Costa Tundisi,Louise Lacalendola Feitosa,Valker de Araújo Breyer,Carlos Alexandre Cardoso,Samuel Leite Mazzola,Priscila Gava Oliveira-Nascimento,Laura de Rangel-Yagui,Carlota de Oliveira Magalhães,Pérola de Oliveira Oliveira,Marcos Antonio de Pessoa Jr,Adalberto |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Jozala,Angela Faustino Geraldes,Danilo Costa Tundisi,Louise Lacalendola Feitosa,Valker de Araújo Breyer,Carlos Alexandre Cardoso,Samuel Leite Mazzola,Priscila Gava Oliveira-Nascimento,Laura de Rangel-Yagui,Carlota de Oliveira Magalhães,Pérola de Oliveira Oliveira,Marcos Antonio de Pessoa Jr,Adalberto |
dc.subject.por.fl_str_mv |
Biopharmaceuticals Fermentation process Biotechnology Upstream process Downstream process |
topic |
Biopharmaceuticals Fermentation process Biotechnology Upstream process Downstream process |
description |
ABSTRACT The use of biopharmaceuticals dates from the 19th century and within 5-10 years, up to 50% of all drugs in development will be biopharmaceuticals. In the 1980s, the biopharmaceutical industry experienced a significant growth in the production and approval of recombinant proteins such as interferons (IFN α, β, and γ) and growth hormones. The production of biopharmaceuticals, known as bioprocess, involves a wide range of techniques. In this review, we discuss the technology involved in the bioprocess and describe the available strategies and main advances in microbial fermentation and purification process to obtain biopharmaceuticals. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822016000500051 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822016000500051 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1016/j.bjm.2016.10.007 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Microbiologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Microbiologia |
dc.source.none.fl_str_mv |
Brazilian Journal of Microbiology v.47 suppl.1 2016 reponame:Brazilian Journal of Microbiology instname:Sociedade Brasileira de Microbiologia (SBM) instacron:SBM |
instname_str |
Sociedade Brasileira de Microbiologia (SBM) |
instacron_str |
SBM |
institution |
SBM |
reponame_str |
Brazilian Journal of Microbiology |
collection |
Brazilian Journal of Microbiology |
repository.name.fl_str_mv |
Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM) |
repository.mail.fl_str_mv |
bjm@sbmicrobiologia.org.br||mbmartin@usp.br |
_version_ |
1752122208795230208 |